Publication
FTC’s watchdog role in pharma mergers: Road bumps and the way forward
The FTC's revised merger guidelines issued in 2023 signify a substantial alteration in antitrust enforcement, notably impacting industries like pharmaceuticals where consolidation is prevalent.